BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4737754)

  • 1. [The haptoglobin level and types in hematological diseases].
    Sezaki T
    Rinsho Ketsueki; 1973 Apr; 14(4):495-501. PubMed ID: 4737754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma fibronectin level in patients with hematologic diseases].
    Savchenko VG; Vasil'ev SA; Ermolin GA; Kotelianskiĭ VE; Efremov EE
    Ter Arkh; 1984; 56(6):28-33. PubMed ID: 6474373
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum haptoglobin level in disseminated malignant diseases in children.
    Moe PJ
    Acta Paediatr Scand; 1970 Jul; 59(4):381-4. PubMed ID: 5447681
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ultrastructure of erythroblasts in various hematological disorders (author's transl)].
    Miura AB; Shibata A; Akihama T; Endo Y; Saito Y
    Rinsho Ketsueki; 1974 Jul; 15(7):756-63. PubMed ID: 4610206
    [No Abstract]   [Full Text] [Related]  

  • 5. The levels of granulocyte colony-stimulating factor in the plasma of the bone marrow aspirate in various hematological disorders.
    Shinohara K; Oeda E; Nomiyama J; Inoue H; Kamei S; Tajiri M; Ichikawa T; Kuwaki T; Tachibana K
    Stem Cells; 1995 Jul; 13(4):421-7. PubMed ID: 7549901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological heterogeneity in human ferritinemia.
    Asakawa H; Taguchi T; Mori W
    Gan; 1976 Jun; 67(3):347-53. PubMed ID: 63405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Values of haptoglobin and hemopexin in some hemolytic disorders].
    Brabec V; Korĩnek J
    Vnitr Lek; 1971 Sep; 17(9):833-41. PubMed ID: 4108525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activity of the fibrin stabilizing factor in several diseases in children].
    Alekseenko IF
    Vopr Okhr Materin Det; 1970 Feb; 15(2):90. PubMed ID: 5462401
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the demonstration of fetal hemoglobins in acquired blood diseases by the elution method].
    Scholz R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):419-35. PubMed ID: 4168278
    [No Abstract]   [Full Text] [Related]  

  • 10. [Post-transfusional serum haptoglobin in hematologic patients].
    de Suárez RE; Barretto OC
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(2):67-9. PubMed ID: 3563294
    [No Abstract]   [Full Text] [Related]  

  • 11. [The behavior of serum haptoglobin in anemias of various origins].
    Cieśluk S; Snigurowicz J
    Pol Tyg Lek; 1970 Jun; 25(26):953-5. PubMed ID: 5448361
    [No Abstract]   [Full Text] [Related]  

  • 12. Superoxide production of polymorphonuclear leukocytes in patients with hematological disorders.
    Kitamura T; Tomonaga M
    Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1487-96. PubMed ID: 6326454
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietic effect of plasma from patients with advanced cancer.
    Firat D; Banzon J
    Cancer Res; 1971 Oct; 31(10):1355-9. PubMed ID: 5106807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the rheologic properties of erythrocytes in various hematologic diseases].
    Fedorova ZD; Abdulkadyrov KM; Bessmel'tsev SS; Kotovshchikova MA
    Gematol Transfuziol; 1989 Feb; 34(2):12-7. PubMed ID: 2707559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the agglutinability of red blood cells from patients with hematologic disorders.
    Buchholz DH; Bove JR
    Transfusion; 1973; 13(1):23-33. PubMed ID: 4685220
    [No Abstract]   [Full Text] [Related]  

  • 16. [The behavior of haptoglobins and Gm factors, as well as their relations to the quantitative alpha-2 and gamma globulin values in diseases of the blood].
    Hunger H; Göhler W; Helwig W
    Klin Wochenschr; 1965 Dec; 43(23):1255-62. PubMed ID: 4162915
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of clinical factors on the haemolysis marker haptoglobin.
    Körmöczi GF; Säemann MD; Buchta C; Peck-Radosavljevic M; Mayr WR; Schwartz DW; Dunkler D; Spitzauer S; Panzer S
    Eur J Clin Invest; 2006 Mar; 36(3):202-9. PubMed ID: 16506966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granulocyte dysfunction in hematological diseases].
    Matzner Y
    Gematol Transfuziol; 1993 May; 38(5):41-4. PubMed ID: 8034174
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombocyte survival in blood diseases].
    Sakhibov IaD; Sagdieva NSh; Makhmudova MA; Novokshchenova LV; Bezinchuk RI; Akhmedzhanov KhA
    Ter Arkh; 1992; 64(12):48-51. PubMed ID: 1292133
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum thrombopoietin level in various hematological diseases.
    Usuki K; Tahara T; Iki S; Endo M; Osawa M; Kitazume K; Kato T; Miyazaki H; Urabe A
    Stem Cells; 1996 Sep; 14(5):558-65. PubMed ID: 8888496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.